We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
What's in Store for Synopsys (SNPS) This Earnings Season?
Read MoreHide Full Article
Synopsys (SNPS - Free Report) is slated to release second-quarter fiscal 2021 results on May 19.
Management expects second-quarter revenues between $970 million and $1 billion. The Zacks Consensus Estimate for the top line is currently pegged at $988.5 million, indicating 14.8% year-on-year growth.
Management expects non-GAAP earnings between $1.50 and $1.55 per share. Notably, the consensus mark for earnings is pegged at $1.52 per share, suggesting 24.6% year-over-year growth.
Let’s see how things have shaped up prior to this announcement.
Synopsys’ fiscal second-quarter performance is likely to have benefited from growing demand for its solid product portfolio. Increasing global design activity and customer engagements are likely to have been its growth drivers.
Moreover, the rising impact of artificial intelligence ("AI), 5G, internet of things, high-performance computing and the Cloud, and automotive is anticipated to have boosted demand for the company’s advanced solutions. Synopsys’ performance is likely to have gained from growth in Custom Compiler, which is fueled by large deal wins in the 5G, AI and server chip markets.
Additionally, widespread contract wins and the increasing deployment of the Fusion Platform, including Fusion Compiler, are anticipated to have been key growth drivers. Synopsys’ Verification Continuum platform witnesses robust demand and competitive gains, which are anticipated to have been major catalysts as well.
Notably, the ongoing shift to high-performance cloud computing owing to the coronavirus-induced remote working environment is expected to have aided demand for the company’s Intellectual Property ("IP") solutions, such as PCI Express, 112G Ethernet and DDR.
Further, the company’s USB4 IP solution for advanced 5nm processes is likely to have driven order growth in the to-be-reported quarter. Also, strong adoption of its interface and foundation IP solutions is expected to have boosted revenues for the company’s interface portfolio.
The company’s solid electronic design automation software partner base, which includes Advanced Micro Devices, Juniper Networks, Realtek, Toshiba and Wolfson, is likely to have served as a major revenue driver.
Additionally, increased design investments in Synopsys’s ARC processors by automotive companies, despite the coronavirus-led headwinds in the automotive space, are positives.
However, partial resumption of normal activities is expected to have brought back certain expenditures, which were on hold during the lockdown and work-from-home period. This might have been a slight drag on margins.
Moreover, geopolitical challenges coupled with uncertainties related to restrictions over trade with Huawei Technologies are likely to have adversely impacted overall business in the second quarter.
What Our Model Says
Our proven model does not predict an earnings beat for Synopsys this time around. The combination of a positive Earnings ESP, and Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold), increases the chances of an earnings beat. But that’s not the case here. You can uncover the best stocks to buy or sell, before they’re reported, with our Earnings ESP Filter.
Synopsys currently carries a Zacks Rank of 4 and has an Earnings ESP of 0.00%.
Stocks With Favorable Combinations
Here are some companies, which, per our model, have the right combination of elements to post an earnings beat in their upcoming releases:
NVIDIA Corporation (NVDA - Free Report) has an Earnings ESP of +2.11% and carries a Zacks Rank #2, at present.
Pure Storage, Inc. (PSTG - Free Report) has an Earnings ESP of +10.81% and currently carries a Zacks Rank #2.
Time to Invest in Legal Marijuana
If you’re looking for big gains, there couldn’t be a better time to get in on a young industry primed to skyrocket from $17.7 billion back in 2019 to an expected $73.6 billion by 2027.
After a clean sweep of 6 election referendums in 5 states, pot is now legal in 36 states plus D.C. Federal legalization is expected soon and that could be a still greater bonanza for investors. Even before the latest wave of legalization, Zacks Investment Research has recommended pot stocks that have shot up as high as +285.9%.
You’re invited to check out Zacks’ Marijuana Moneymakers: An Investor’s Guide. It features a timely Watch List of pot stocks and ETFs with exceptional growth potential.
Image: Shutterstock
What's in Store for Synopsys (SNPS) This Earnings Season?
Synopsys (SNPS - Free Report) is slated to release second-quarter fiscal 2021 results on May 19.
Management expects second-quarter revenues between $970 million and $1 billion. The Zacks Consensus Estimate for the top line is currently pegged at $988.5 million, indicating 14.8% year-on-year growth.
Management expects non-GAAP earnings between $1.50 and $1.55 per share. Notably, the consensus mark for earnings is pegged at $1.52 per share, suggesting 24.6% year-over-year growth.
Let’s see how things have shaped up prior to this announcement.
Synopsys, Inc. Price and Consensus
Synopsys, Inc. price-consensus-chart | Synopsys, Inc. Quote
Factors at Play
Synopsys’ fiscal second-quarter performance is likely to have benefited from growing demand for its solid product portfolio. Increasing global design activity and customer engagements are likely to have been its growth drivers.
Moreover, the rising impact of artificial intelligence ("AI), 5G, internet of things, high-performance computing and the Cloud, and automotive is anticipated to have boosted demand for the company’s advanced solutions. Synopsys’ performance is likely to have gained from growth in Custom Compiler, which is fueled by large deal wins in the 5G, AI and server chip markets.
Additionally, widespread contract wins and the increasing deployment of the Fusion Platform, including Fusion Compiler, are anticipated to have been key growth drivers. Synopsys’ Verification Continuum platform witnesses robust demand and competitive gains, which are anticipated to have been major catalysts as well.
Notably, the ongoing shift to high-performance cloud computing owing to the coronavirus-induced remote working environment is expected to have aided demand for the company’s Intellectual Property ("IP") solutions, such as PCI Express, 112G Ethernet and DDR.
Further, the company’s USB4 IP solution for advanced 5nm processes is likely to have driven order growth in the to-be-reported quarter. Also, strong adoption of its interface and foundation IP solutions is expected to have boosted revenues for the company’s interface portfolio.
The company’s solid electronic design automation software partner base, which includes Advanced Micro Devices, Juniper Networks, Realtek, Toshiba and Wolfson, is likely to have served as a major revenue driver.
Additionally, increased design investments in Synopsys’s ARC processors by automotive companies, despite the coronavirus-led headwinds in the automotive space, are positives.
However, partial resumption of normal activities is expected to have brought back certain expenditures, which were on hold during the lockdown and work-from-home period. This might have been a slight drag on margins.
Moreover, geopolitical challenges coupled with uncertainties related to restrictions over trade with Huawei Technologies are likely to have adversely impacted overall business in the second quarter.
What Our Model Says
Our proven model does not predict an earnings beat for Synopsys this time around. The combination of a positive Earnings ESP, and Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold), increases the chances of an earnings beat. But that’s not the case here. You can uncover the best stocks to buy or sell, before they’re reported, with our Earnings ESP Filter.
Synopsys currently carries a Zacks Rank of 4 and has an Earnings ESP of 0.00%.
Stocks With Favorable Combinations
Here are some companies, which, per our model, have the right combination of elements to post an earnings beat in their upcoming releases:
HP Inc. (HPQ - Free Report) has an Earnings ESP of +4.49% and currently carries a Zacks Rank of 2. You can see the complete list of today’s Zacks #1 Rank stocks here.
NVIDIA Corporation (NVDA - Free Report) has an Earnings ESP of +2.11% and carries a Zacks Rank #2, at present.
Pure Storage, Inc. (PSTG - Free Report) has an Earnings ESP of +10.81% and currently carries a Zacks Rank #2.
Time to Invest in Legal Marijuana
If you’re looking for big gains, there couldn’t be a better time to get in on a young industry primed to skyrocket from $17.7 billion back in 2019 to an expected $73.6 billion by 2027.
After a clean sweep of 6 election referendums in 5 states, pot is now legal in 36 states plus D.C. Federal legalization is expected soon and that could be a still greater bonanza for investors. Even before the latest wave of legalization, Zacks Investment Research has recommended pot stocks that have shot up as high as +285.9%.
You’re invited to check out Zacks’ Marijuana Moneymakers: An Investor’s Guide. It features a timely Watch List of pot stocks and ETFs with exceptional growth potential.
Today, Download Marijuana Moneymakers FREE >>